Company Overview and News

3
After emerging-market rout, Investec ready to start buying again

4h theedgemarkets
SINGAPORE (July 17): Investec Asset Management, which oversees US$36 billion in emerging-market fixed income, is ready to get back into the market after reducing risks at the start of the year.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

5
Boeing rethinks aerospace rulebook as ‘797’ plans take shape

2018-07-15 malaymail
CHICAGO, July 15 — Boeing Co is seeking to rewrite the rules for creating commercial jets as it hones plans for a new midrange jet nicknamed the 797.
DSLV VIIX DGLD CSSLF VIIZ SPR UTX CS CSGKF UGLD BOE ZIV USLV TVIX BA XIV

5
The most expensive city in the world to eat in

2018-07-13 theage.com.au
The Swiss city is the most expensive in the world for food, according to UBS Group AG's Prices and Earnings report for 2018, a survey ranking global city prices, earning levels, purchasing power and working time to buy common goods.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

5
The most expensive city in the world to eat in

2018-07-13 smh.com.au
The Swiss city is the most expensive in the world for food, according to UBS Group AG's Prices and Earnings report for 2018, a survey ranking global city prices, earning levels, purchasing power and working time to buy common goods.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

9
Wall Street Competes With Unregulated Banks for the Riskiest Loans - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
NMR MQBKY DB DGLD GS.PRB GS.PRA CS GS UGLD GLSSP 8604 NRSCF JEF MQG JBK DSLV VIIX GSC GS.PRICL CSSLF VIIZ TFG MCQEF GSJ GS.PRJ GS.PRI CSGKF N33 GS.PRD GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

3
Asia’s newest millionaires swap basket-case economy for fine art

2018-07-12 bworldonline
IN THE PHILIPPINES, where a fifth of the country lives beneath the poverty line, locals have a new obsession: fine art.
JBARF DSLV VIIX DGLD CSSLF VIIZ BDOUY AYAAY CS JBAXY BDOUF BDO CSGKF UGLD ZIV USLV TVIX ALI AYAAF XIV

5
These Are the Most Expensive Cities in the World - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DSLV VIIX DGLD CSSLF VIIZ CS CSGKF UGLD UBS UBS.PRDCL ZIV USLV TVIX ULSGF XIV

3
Asia's Newest Millionaires Swap Basket-Case Economy for Fine Art - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBARF DSLV VIIX DGLD CSSLF VIIZ BDOUY AYAAY CS JBAXY BDOUF BDO CSGKF UGLD ZIV USLV TVIX ALI AYAAF XIV

3
A Banker, an Intern and a Reckoning for Wall Street Bro Culture - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

3
A banker, an intern and a reckoning for Wall Street 'bro' culture

2018-07-11 theage.com.au
On Tuesday, after weeks of rumbling inside Credit Suisse, Paul Dexter, a senior banker, was let go over a complaint of inappropriate behavior involving an intern. Rumours swirled in M&A circles.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

3
A banker, an intern and a reckoning for Wall Street 'bro' culture

2018-07-11 smh.com.au
On Tuesday, after weeks of rumbling inside Credit Suisse, Paul Dexter, a senior banker, was let go over a complaint of inappropriate behavior involving an intern. Rumours swirled in M&A circles.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

37
Oakmark Global Fund: Second Quarter 2018

2018-07-11 seekingalpha
The Oakmark Global Fund’s three-month return declined 0.3%, compared to a 1.7% return for the MSCI World Index during the period and the Lipper Global Fund Index’s gain of 0.4%.
DGLD LBTY NOV UAA TEL GOOG IPG CS CHTR UGLD LBTYK LILAB GM.WS.A GM.WS.B GM.WS.C GM LUV CNHI LBRDB DSLV VIIX CSSLF VIIZ LBTYB MA LBTYA ARNC DDAIF RB LBRDK UA CSGKF GOOGL LILAK ZIV RBGLY LBRDA USLV TVIX GM.WSB THC TV XIV LILA

5
MOVES-HSBC appoints Alexander Glawe as managing director

2018-07-11 reuters
July 11 (Reuters) - HSBC Holdings Plc said on Wednesday it had named Alexander Glawe managing director, head of Northern Europe Financial Sponsors, effective December.
HCS.PRB DSLV VIIX DGLD CSSLF VIIZ HCS CS HSB 0005 CSGKF UGLD UBS HSEA UBS.PRDCL HSEB ZIV USLV HSBC.PRA TVIX HSBC ULSGF HBCYF XIV

3
Credit Suisse nears US$360 million deadline in fraud suit built on a hunch

2018-07-11 channelnewsasia
CHICAGO: When the high-end property development Lake Las Vegas collapsed during the 2008 financial crisis, 31 funds that helped finance the project lost a total of US$540 million. But only one of them, Dallas-based hedge fund Highland Capital Management, aggressively pursued legal action against Credit Suisse Group AG, which arranged the financing and appraisals for the project.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

3
Credit Suisse nears $360 million deadline in fraud suit built on a hunch

2018-07-11 reuters
CHICAGO (Reuters) - When the high-end property development Lake Las Vegas collapsed during the 2008 financial crisis, 31 funds that helped finance the project lost a total of $540 million. But only one of them, Dallas-based hedge fund Highland Capital Management, aggressively pursued legal action against Credit Suisse Group AG, which arranged the financing and appraisals for the project.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 22542D795